Creative Biolabs focuses on continuous innovation of the one-stop exosome platform to assist customers in better exploring the applications and mechanisms of BMMSCs-Exo (bone marrow mesenchymal stem cell-derived exosomes).
BMMSCs-Exo modify target cell fate mainly through the secretion of bioactive factors and directed differentiators. Its content secretion is linearly related to the number of inoculated cells, promotes the expansion of osteoblasts, myoblasts, and neuronal populations, and is involved in inflammatory regulatory functions, hematopoietic support, neuroprotection, and ovarian development.
Fig. 1 Intravenous injection or inhalation of BMMSCs-EXO.1
Creative Biolabs summarizes the application of BMMSCs-Exo in multiple fields and focuses on demystifying exosome science. Please contact us to discuss your BMMSCs-Exo project and gain access to the possibilities of exciting research discoveries.
A: In stem cell research, exosomes have emerged as key players in intercellular communication, mediating stem cell differentiation, immune modulation, and tissue repair, making them promising therapeutic candidates.
A: Found in bone marrow, BM-MSCs are multipotent stem cells that can develop into chondrocytes, osteoblasts, myocytes and adipocytes among other cell types. They possess immunomodulatory properties and are easily accessible for clinical applications. BM-MSC-derived exosomes retain many of the beneficial properties of their parent cells, such as promoting tissue regeneration, inhibiting inflammation, and supporting cell survival and proliferation. Thus, they are an attractive source for developing therapeutic exosomes.
A: BM-MSC-derived exosomes show promise in treating a wide range of diseases and injuries due to their ability to promote tissue repair, reduce inflammation, and modulate immune responses. Some potential applications include:
A: BM-MSC-derived exosomes mediate their effects through several mechanisms, including:
Reference